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Background: Cirrhotic patients admitted to an intensive care unit (ICU) have high mortality rates. The present
study compared the characteristics and outcomes of critically ill patients admitted to the ICU with and without
cirrhosis using the matched Acute Physiology and Chronic Health Evaluation III (APACHE III) and Sequential Organ
Failure Assessment (SOFA) scores.
Methods: A retrospective case-control study was performed at the medical ICU of a tertiary-care hospital between
January 2006 and December 2009. Patients were admitted with life-threatening complications and were matched
for APACHE III and SOFA scores. Of 336 patients enrolled in the study, 87 in the cirrhosis or noncirrhosis group were
matched according to the APACHE III scores. Another 55 patients with cirrhosis were matched to the 55 patients
without cirrhosis according to the SOFA scores. Demographic data, aetiology of ICU admission, and laboratory
variables were also evaluated.
Results: The overall hospital mortality rate in the patients with cirrhosis in the APACHE III-matched group was more
than that in their counterparts (73.6% vs 57.5%, P = .026) but the rate did not differ significantly in the SOFA-matched
group (61.8% vs 67.3%). In the APACHE III-matched group, the SOFA scores of patients with cirrhosis were significantly
higher than those of patients without cirrhosis (P < .001), whereas the difference in APACHE III scores was nonsignificant
between the SOFA-matched patients with and without cirrhosis.
Conclusions: Score-matched analytical data showed that the SOFA scores significantly differentiated the patients
admitted to the ICU with cirrhosis from those without cirrhosis in APACHE III-matched groups, whereas difference in the
APACHE III scores between the patients with and without cirrhosis were nonsignificant in the SOFA-matched group.
Keywords: Acute physiology and chronic health evaluation III (APACHE III), Sequential organ failure assessment (SOFA),
Intensive care unit (ICU), Cirrhosis, OutcomeBackground
Accurate prognostic predictors are crucial for patients
admitted to an intensive care unit (ICU). Prognostic
scoring systems are useful for clinical management such as
predicting a survival rate, making decisions, and facilitating
explanation of disease severity, by clinical physicians. Pa-
tients with cirrhosis admitted to an ICU frequently have* Correspondence: cyc2356@adm.cgmh.org.tw
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unless otherwise stated.disappointing outcomes despite intensive medical support,
and these patients are particular targets for prognostic
evaluation.
Various systems for scoring severity and predicting
prognosis have been developed and applied for decades.
The Acute Physiology and Chronic Health Evaluation III
(APACHE III) score [1], one of the widely used scoring
systems, is known for its accuracy in predicting mortality.
However, the APACHE III scoring system was initially
developed for various diseases and not exclusively for
liver-related diseases. By contrast, the Sequential Organ
Failure Assessment (SOFA) score [2], another widely usedThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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system for assessing specific organ dysfunction including
cirrhosis [3,4]. Our previous study demonstrated that the
APACHE III and SOFA scores were both independently
associated with a hospital mortality rate and demonstrated
high discriminatory power for predicting mortality in
patients with cirrhosis [5]. However, few studies have
performed detailed independent comparisons between
APACHE III and SOFA scores [6]. In the present case-
control study, we matched APACHE III and SOFA scores
and compared the different clinical characteristics and




The Chang Gung Medical Foundation Institutional Review
Board approved the present study and waived the need
for informed consent, because patient privacy was not
breached during the study, and the study did not interfere
with clinical decisions related to patient care (approval
No. 98-3658A3). All data in our study were anonymised.
This retrospective case-control study was conducted in a
tertiary-care hospital. The enrolled patients were recruited
from a database of critically ill patients admitted to medical
ICUs between January 2006 and December 2009. For the
APACHE III-matched group (174 patients), each patient
with cirrhosis was matched 1:1 to a control patient without
cirrhosis by using the criteria of APACHE III ± 3 points.
For the SOFA-matched group (110 patients), each patient
with cirrhosis was matched 1:1 to a control patient without
cirrhosis by using the criteria of SOFA± 1 point [7,8]. The
outcomes of interest were the length of stay in an ICU,
length of stay in a hospital, and hospital mortality rate.
Study population and data collection
All patients admitted to medical ICUs between January
2006 and December 2009 with APACHE III and SOFA
scores available were eligible for inclusion. Exclusion
criteria were age < 18 years, length of stay in a hospital
or an ICU of < 24 hours, patients with chronic uraemia
and undergoing renal replacement therapy, and hospital
readmission. Data were recorded regarding patient demo-
graphics, reason for ICU admission, clinical and labora-
tory variables, APACHE III and SOFA scores, the risk
of renal failure, injury to the kidney, failure of kidney
function, loss of kidney function, end-stage renal failure
(RIFLE) classification [9], the length of stay in an ICU and
a hospital, and hospital mortality. Data on the length of
stay included those from patients with hospital mortality.
Definitions
Cirrhosis was diagnosed based on liver histology or a com-
bination of physical presentation, biochemical data, andultrasonographic findings. Illness severity was assessed
according to the APACHE III and the SOFA scores, which
were defined and calculated as described previously [1,2].
Acute kidney injury (AKI) was defined using the RIFLE
criteria, and patients were scored as RIFLE-R or higher
severity. Baseline serum creatinine (SCr) concentration was
the first value measured during hospitalisation. The Modifi-
cation of Diet in Renal Disease formula was used to esti-
mate baseline SCr concentration in patients whose previous
SCr concentration was unavailable. The criteria resulting in
the most severe RIFLE classification were used [9]. A sim-
ple model for assessing mortality was developed as follows:
non-AKI (0 points), RIFLE-R (1 point), RIFLE-I (2 points),
and RIFLE-F (3 points) on Day 1 of ICU admission [10,11].
The lowest physiological and biochemical values on Day
1 of ICU admission were recorded. In sedated or paralysed
patients, neurological scoring was not performed and was
not classified as neurological failure. In patients who were
intubated but not sedated, the best verbal response was
determined according to clinical judgment.
Statistical analysis
Descriptive statistical results were expressed as mean ±
standard error (SE). In primary analysis, the patients with
cirrhosis were compared with the patients without cirrho-
sis. All variables were tested for normal distribution using
the Kolmogorov–Smirnov test. Student’s t-test was used
to compare the means of continuous variables and nor-
mally distributed data, whereas the Mann–Whitney U test
was used for all other comparisons. Categorical data were
tested using the χ2 test or Fisher’s exact test.
Calibration was assessed using the Hosmer–Lemeshow
goodness-of-fit test (C statistic) to compare the number
of observed and predicted deaths in various risk groups for
the entire range of death probabilities. Discrimination was
assessed by determining area under the receiver operating
characteristic curve (AUROC). Areas under 2 receiver oper-
ating characteristic curves were compared by applying a
nonparametric approach. The AUROC analysis was also
conducted to estimate the cut-off values, sensitivity, specifi-
city, overall correctness, and positive and negative predictive
values. Finally, cut-off points were calculated by determining
the best Youden’s index (sensitivity + specificity −1).
Cumulative survival curves over time were generated
by applying the Kaplan–Meier approach and compared
using the log rank test. All statistical tests were 2-tailed;
P < .05 was considered statistically significant. Data were
analysed using SPSS Version 13.0 for Windows (SPSS,
Inc., Chicago, IL, USA).
Results
Patient characteristics
A total of 336 critically ill patients admitted to the medical
ICU between January 2006 and December 2009 were






Urinary tract infection 9(5.2%) 8(7.3%)
Pneumonia 62(35.6%) 38(34.5%)
Intra-abdominal infection 16(9.2%) 7(6.4%)
Blood stream infection 9(5.2%) 8(7.3%)
Soft tissue infection 3(1.7%) 1(0.9%)




Hepatic failure 34(19.5%) 23(20.9%)
Other 19(10.9%) 11(10.0%)
Abbreviation: ICU, intensive care unit; APACHE, Acute Physiology and Chronic
Health Evaluation; SOFA, sequential organ failure assessment.
Table 2 APACHE III-matched patient demographic data and c
non-cirrhosis
Total (n = 174)
Age (years) 65.5 ± 1.1
Male/Female 123/51
Length of ICU stay (days) 14 ± 1
Length of Hospital stay (days) 32 ± 2
Body weight on ICU admission (kg) 61 ± 1.0
GCS, ICU first day (points) 9 ± 0
MAP, ICU admission (mmHg) 78 ± 1
Serum Creatinine, ICU first day (mg/dl) 2.5 ± 0.2
Arterial HCO3
−, ICU first day 21 ± 1
Serum Sodium, ICU first day (mg/dl) 138 ± 1.0
Bilirubin, ICU first day (mg/dl) 6.4 ± 0.7
Albumin, ICU first day (g/l) 2.4 ± 0.1
Blood Sugar, ICU first day (mg/dl) 166 ± 7
Hemoglobin, ICU first day (g/dl) 9.6 ± 0.2
Platelets, ICU first day (×103/μL) 145.0 ± 9.1
Leukocytes, ICU first day (×103/μL) 14.5 ± 0.7
PaO2/FiO2, ICU first day(mmHg) 268 ± 11
Shock(%) 54 (31.0)
Hospital mortality (%) 114 (65.5)
Score systems
APACHE III, ICU first day(mean ± SE) 87.8 ± 2.1
SOFA, ICU first day(mean ± SE) 9.6 ± 0.3
RIFLE, ICU first day(mean ± SE) 1.6 ± 0.1
Abbreviation: NS, not significant; ICU, intensive care unit; SE, standard error; GCS, Gl
of oxygen; FiO2, fraction of inspired oxygen; APACHE, Acute Physiology and Chroni
renal failure, injury to the kidney, failure of kidney function, loss of kidney function,
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ICU admission. The demographic data, clinical character-
istics, and outcomes of the 2 score-matched groups are
depicted in Tables 2 and 3, respectively.
In the APACHE III-matched group (Table 2), the critic-
ally ill patients with cirrhosis had a lower arterial HCO3
−
level (P = .002), a lower haemoglobin level (P = .024), a
lower platelet count (P < .001), and a higher serum biliru-
bin level (P < .001) on Day 1 of ICU admission compared
with the patients without cirrhosis. The patients without
cirrhosis with the same score were older and experienced
more shock episodes than the patients with cirrhosis did.
The hospital mortality rate was significantly higher in
the patients with cirrhosis than in the patients without
cirrhosis (P = .026). Renal function and a PaO2/FiO2
ratio were similar between the 2 groups. Among APA-
CHE III-matched patients, the patients with cirrhosis
had significantly higher SOFA scores than those of the
patients without cirrhosis (P < .001).
In the SOFA-matched group (Table 3), the patients
with cirrhosis had a lower platelet count (P < .001), alinical characteristics according to cirrhosis and
Cirrhosis (n = 87) Non-cirrhosis (n = 87) p-value
59.8 ± 1.5 71.3 ± 1.4 <0.001
64/23 59/28 NS(0.405)
11 ± 1 16 ± 2 0.009
30 ± 3 35 ± 3 NS(0.223)
65 ± 1 57 ± 1 <0.001
10 ± 1 9 ± 1 NS(0.077)
80 ± 2 76 ± 2 NS(0.137)
2.4 ± 0.2 2.5 ± 0.3 NS(0.885)
19 ± 1.0 22 ± 1.0 0.002
138 ± 1.0 138 ± 1.0 NS(0.890)
11.4 ± 1.3 1.4 ± 0.3 <0.001
2.4 ± 0.1 2.4 ± 0.1 NS(0.329)
159 ± 11 170 ± 10.0 NS(0.482)
9.2 ± 0.2 10.0 ± 0.2 0.024
79.4 ± 5.9 210.5 ± 14.1 <0.001
13.5 ± 1.0 15.5 ± 0.8 NS(0.133)
275 ± 13 262 ± 17 NS(0.536)
21 (24.1) 33 (37.9) 0.049
64 (73.6) 50 (57.5) 0.026
87.7 ± 3.4 88.0 ± 2.5 NS(0.941)
11.3 ± 0.4 8.0 ± 0.3 <0.001
1.6 ± 0.1 1.7 ± 0.2 NS(0.913)
asgow coma scale; MAP, mean arterial pressure; PaO2, arterial partial pressure
c Health Evaluation; SOFA, sequential organ failure assessment; RIFLE, risk of
and end-stage renal failure.
Table 3 SOFA-matched patient demographic data and clinical characteristics according to cirrhosis and non-cirrhosis
Total (n = 110) Cirrhosis (n = 55) Non-cirrhosis (n = 55) p-value
Age (years) 65.0 ± 1.4 61.1 ± 2.0 68.9 ± 2.0 0.006
Male/Female 79/31 40/15 39/16 NS(0.832)
Length of ICU stay (days) 14 ± 1 11 ± 1 18 ± 2 0.007
Length of Hospital stay (days) 31 ± 2 32 ± 4 31 ± 3 NS(0.843)
Body weight on ICU admission (kg) 60 ± 1 64 ± 2 56 ± 2 0.001
GCS, ICU first day (points) 10 ± 0 11 ± 1 8 ± 1 0.005
MAP, ICU admission (mmHg) 78 ± 2 83 ± 2 73 ± 2 0.002
Serum Creatinine, ICU first day (mg/dl) 2.4 ± 0.2 1.8 ± 0.2 3.0 ± 0.3 0.004
Arterial HCO3
−, ICU first day 21 ± 1 20 ± 1 21 ± 1 NS(0.458)
Serum Sodium, ICU first day (mg/dl) 137 ± 1 138 ± 1 137 ± 1 NS(0.282)
Bilirubin, ICU first day (mg/dl) 5.8 ± 0.8 9.6 ± 1.5 1.9 ± 0.4 <0.001
Albumin, ICU first day (g/l) 2.4 ± 0.1 2.5 ± 0.1 2.3 ± 0.1 0.016
Blood Sugar, ICU first day (mg/dl) 160 ± 8 159 ± 12 161 ± 11 NS(0.899)
Hemoglobin, ICU first day (g/dl) 9.7 ± 0.2 9.3 ± 0.3 10.0 ± 0.3 NS(0.134)
Platelets, ICU first day (×103/μL) 127.3 ± 10.1 85.8 ± 8.1 168.8 ± 16.9 <0.001
Leukocytes, ICU first day (×103/μL) 13.9 ± 0.8 12.9 ± 1.3 14.9 ± 1.0 NS(0.224)
PaO2/FiO2, ICU first day(mmHg) 256 ± 13 270 ± 16 243 ± 19 NS(0.299)
Shock(%) 39 (35.5) 9 (16.3) 30 (54.5) <0.001
Hospital mortality (%) 71(64.5) 34 (61.8) 37 (67.3) NS(0.550)
Score systems
APACHE III, ICU first day(mean ± SE) 86.5 ± 2.8 81.1 ± 4.2 91.9 ± 3.7 NS(0.058)
SOFA, ICU first day(mean ± SE) 10.0 ± 0.3 10.0 ± 0.5 10.0 ± 0.3 NS(0.927)
RIFLE, ICU first day(mean ± SE) 1.6 ± 0.1 1.4 ± 0.2 1.9 ± 0.2 0.041
Abbreviation: NS, not significant; ICU, intensive care unit; SE, standard error; GCS, Glasgow coma scale; MAP, mean arterial pressure; PaO2, arterial partial pressure
of oxygen; FiO2, fraction of inspired oxygen; APACHE, Acute Physiology and Chronic Health Evaluation; SOFA, sequential organ failure assessment; RIFLE, risk of
renal failure, injury to the kidney, failure of kidney function, loss of kidney function, and end-stage renal failure.
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dynamic status, more favourable renal function, a higher
bilirubin level, and a lower albumin level compared with
the patients without cirrhosis. The patients without
cirrhosis experienced more shock episodes than did the
patients with cirrhosis. No significant difference in the
hospital mortality rate was observed between the patients
with and without cirrhosis.
In both the APACHE III and SOFA-matched groups,
the patients with cirrhosis had a shorter overall length
of stay in an ICU than that of the patients without
cirrhosis. This was attributed to the higher hospital
mortality rate in the patients with cirrhosis. In both the
APACHE III and SOFA-matched groups, the patients
without cirrhosis had a significantly higher rate of
shock than the patients with cirrhosis did. This was
because of the main reason that ICU admission of the
patients with cirrhosis was mainly due to hepatic
failure; the reasons for ICU admission of the patients
without cirrhosis were GI bleeding and sepsis. (Data
not shown here)Mortality and severity of illness scoring systems
Prediction abilities of the APACHE III, SOFA, and RI-
FLE scoring systems were compared; Table 4 lists the
calibration and discrimination of the models. In the
APACHE III-matched group, the SOFA scoring system
demonstrated the highest prediction ability (AUROC =
0.810 ± 0.056) among all 3 systems. All the 3 scoring sys-
tems predicted mortality more precisely in the patients
with cirrhosis than in those without cirrhosis. In the
SOFA-matched group, the APACHE III scoring system
was the most accurate predictor among all 3 systems. In
the patients with cirrhosis, the SOFA scoring system
demonstrated the highest prediction ability. To determine
the selected cut-off points for predicting in-hospital mor-
tality, the sensitivity, specificity, and overall accuracy of
prediction were determined (Table 5). In the APACHE III-
matched group, the SOFA scoring system had the best
Youden’s index among the patients with cirrhosis, whereas
the APACHE III scoring system had the best Youden’s
index among the total population. In the SOFA-matched
group, the APACHE III scoring system had the best
Table 4 Calibration and discrimination for the scoring methods in predicting hospital mortality
Calibration Discrimination
goodness-of-fit (χ2) df p AUROC ± SE 95% CI p
APACHE III-matched group
APACHE III
Total population 3.633 8 0.889 0.745 ± 0.040 0.667 – 0.823 <0.001
Cirrhosis 12.304 7 0.091 0.783 ± 0.062 0.662 – 0.904 <0.001
Non-cirrhosis 3.819 8 0.873 0.733 ± 0.055 0.626 – 0.840 <0.001
SOFA
Total population 4.505 8 0.809 0.735 ± 0.039 0.659 – 0.812 <0.001
Cirrhosis 11.243 8 0.188 0.810 ± 0.056 0.700 – 0.920 <0.001
Non-cirrhosis 1.180 6 0.978 0.624 ± 0.060 0.506 – 0.741 NS(0.050)
RIFLE
Total population 3.160 3 0.368 0.621 ± 0.045 0.534 – 0.709 0.010
Cirrhosis 2.008 2 0.366 0.710 ± 0.061 0.590 – 0.830 0.004
Non-cirrhosis 2.475 3 0.480 0.554 ± 0.062 0.431 – 0.676 NS(0.395)
SOFA-matched group
APACHE III
Total population 5.093 8 0.748 0.733 ± 0.051 0.633 – 0.834 <0.001
Cirrhosis 15.201 7 0.034 0.767 ± 0.068 0.633 – 0.900 0.001
Non-cirrhosis 1.716 7 0.974 0.706 ± 0.077 0.556 – 0.856 0.014
SOFA
Total population 6.519 6 0.368 0.663 ± 0.053 0.559 – 0.767 0.005
Cirrhosis 6.427 6 0.377 0.742 ± 0.068 0.608 – 0.875 0.003
Non-cirrhosis 5.698 5 0.337 0.543 ± 0.079 0.387 – 0.698 NS(0.609)
RIFLE
Total population 4.609 3 0.203 0.634 ± 0.055 0.527 – 0.742 0.020
Cirrhosis 1.216 2 0.544 0.656 ± 0.074 0.511 – 0.801 NS(0.053)
Non-cirrhosis 4.531 3 0.210 0.594 ± 0.083 0.432 – 0.756 NS(0.262)
Abbreviation: df, degree of freedom; AUROC, areas under the receiver operating characteristic curve; SE, standard error; CI, confidence intervals; APACHE, Acute
Physiology and Chronic Health Evaluation; SOFA, sequential organ failure assessment; RIFLE, risk of renal failure, injury to the kidney, failure of kidney function,
loss of kidney function, and end-stage renal failure.
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and the total population. The RIFLE scoring system dem-
onstrated the highest specificity for prognostic prediction
in the patients with cirrhosis of both the SOFA-matched
and APACHE III-matched groups.
Figure 1A and B show the cumulative survival rates in
the patients with and without cirrhosis in the APACHE
III-matched and SOFA-matched groups, respectively.
The cumulative survival rates showed that patients with
cirrhosis in the APACHE III-matched group had signifi-
cantly higher mortality rates than the patients without
cirrhosis did, whereas no significant difference was detected
between the patients with and without cirrhosis in the
SOFA-matched group. In both the APACHE III-matched
and SOFA-matched groups, the cumulative survival rates
significantly differed when an underlying AKI was consid-
ered (Figure 2A and B).Discussion
Based on our research, this is the first study to compare
the usefulness of different scoring systems for outcome
prediction in patients admitted to an ICU with and with-
out cirrhosis by using a score-matched method. In the
present study, several clinical characteristics and outcomes
of critically ill patients with cirrhosis were compared with
those of critically ill patients without cirrhosis with
matched APACHE III or SOFA scores. The poor outcome
of patients with cirrhosis was consistent with the results
of previous studies [12-14]. Recent studies have supported
the efficacy of the SOFA scoring system for assessing the
extent of organ dysfunction in various groups including
critically ill patients with cirrhosis [3-5].
The APACHE III score consisted of the acute physiology
score, age, and chronic health problem scores, which are
widely used for predicting clinical outcomes currently.
Table 5 Subsequent hospital mortality predicted after ICU admission
Predictive Factors Cutoff Point Youden index Sensitivity (%) Specificity (%) Overall correctness (%)
APACHE III-matched group
APACHE III
Total population 83 0.42 75 67 71
Cirrhosis 72a 0.55 78 76 77
Non-cirrhosis 83 0.40 70 70 70
SOFA
Total population 10 0.40 52 88 70
Cirrhosis 10a 0.56 75 81 78
Non-cirrhosis 9 0.20 36 84 60
RIFLE
Total population Injury 0.22 39 83 61
Cirrhosis injurya 0.35 45 90 68
Non-cirrhosis Injury 0.10 32 78 55
SOFA-matched group
APACHE III
Total population 76 0.41 75 67 071
Cirrhosis 71a 0.50 74 76 75
Non-cirrhosis 83 0.40 73 67 70
SOFA
Total population 10 0.30 45 85 65
Cirrhosis 10 a 0.42 56 86 71
Non-cirrhosis 10 0.18 35 83 59
RIFLE
Total population Non-AKI 0.22 76 46 61
Cirrhosis Injurya 0.26 35 90 63
Non-cirrhosis Non-AKI 0.20 86 33 60
Abbreviation: APACHE, Acute Physiology and Chronic Health Evaluation; SOFA, sequential organ failure assessment; RIFLE, risk of renal failure, injury to the kidney,
failure of kidney function, loss of kidney function, and end-stage renal failure.
aValue giving the best Youden index.
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incidences of cirrhosis were higher than those among the
patients without cirrhosis. Results of the present study
suggested that among patients with the same APACHE III
score, patients with cirrhosis were older with a higher risk
of acidaemia and shock than those without cirrhosis.
However, renal function and consciousness status were
nonsignificantly different between the 2 groups. The re-
quirement for mechanical ventilation was not included in
the APACHE III score, and no difference in the PaO2/
FiO2 ratio was observed.
Although the SOFA score includes a fewer number of
items and does not assess age and comorbid conditions,
it enhances its simplicity and demonstrates high discrim-
inatory power for predicting critically ill patients with
cirrhosis. The patients with cirrhosis in the SOFA-matched
group showed higher GCS and lower SCr concentrations
on Day 1 of ICU admission, whereas these differences werenonsignificant in the APACHE III-matched group. Because
patients with cirrhosis typically have higher serum bilirubin
levels and lower platelet counts (caused by de novo liver
disease), which contribute to a higher SOFA score, than
their counterparts do, the patients with cirrhosis with
similar SOFA scores may have relatively improved charac-
teristics in the other 5 organic fields. This phenomenon is
consistent with our findings showing that the patients
with cirrhosis had a more stable neurologic status and
renal function than did the patients without cirrhosis in
the SOFA-matched group.
APACHE III, a prognostic model, predicts mortality.
Prognostic scoring models such as APACHE III assume
that mortality is affected by physiological disturbances
that occur early in the course of illness, whereas organ
dysfunction-scoring systems such as SOFA allow determin-
ation of organ dysfunction at the time of admission and at
regular intervals throughout the stay in an ICU, thus
Figure 1 The cumulative survival rates for cirrhotic and
non-cirrhotic patients in the APACHE III-matched (1A, 174 patients,
p < 0.05) and SOFA-matched (1B, 110 patients, p-value: not
significant) groups, respectively.
Figure 2 The cumulative survival rates for acute kidney injury
(AKI) and non-AKI patients in the APACHE III-matched (2A, 174
patients, p< 0.05) and SOFA-matched (2B, 110 patients, p< 0.05)
groups, respectively.
Fu et al. BMC Anesthesiology 2014, 14:123 Page 7 of 8
http://www.biomedcentral.com/1471-2253/14/123allowing for the assessment of changes in organ function.
The SOFA score is an organ dysfunction score that quanti-
fies the burden of organ dysfunction. Although the SOFA
score was originally used to describe morbidity, it was also
used in mortality prediction. The accuracy of mortality
predictions may be improved with repeated measurements
by using organ dysfunction scoring systems such as SOFA.
As shown in Table 4, in the APACHE III-matched group,
the SOFA score demonstrated a higher discrimination abil-
ity in the patients with cirrhosis than in the patients with-
out cirrhosis (AUROC = 0.810 ± 0.056 vs 0.624 ± 0.060).
The SOFA score is simpler for assessment than the
APACHE III score by clinicians. Meanwhile, the SOFA
score allows for sequential measurements and more accur-
ately reflects the dynamic aspects of disease processes andmay provide information of higher quality on the mortality
risk. Therefore, the SOFA score is a superior and easier-to-
implement model for predicting mortality in the patients
with cirrhosis, with a cut-off value of 10 points, providing
the optimal overall correctness. In addition, both the SOFA
and APACHE III scores are comparable in the patients
without cirrhosis.
When the patients with and without cirrhosis were
matched by using SOFA scores, difference in APACHE
III scores between the 2 groups was nonsignificant in
the present study. The RIFLE scoring system, however,
showed superior results in patients with cirrhosis to those
of the noncirrhotic controls (P = .041) in the SOFA-
matched group. The patients with cirrhosis tend to have
malnutrition, low muscle mass, and impaired synthesis of
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based on the serum creatinine and urine output, may lead
to underestimation of AKI severity and overall illness.
Despite the encouraging results of the present study,
several potential limitations should be considered. First,
this was a retrospective study performed at a single
tertiary-care medical centre, which limits generalisation
of the findings. Second, the patients without cirrhosis
mainly composed of patients with sepsis and those with
a low proportion of patients with other diseases such as
cardiovascular disease or acute respiratory distress syn-
drome. The specificity of the subgroup of the patients with
cirrhosis may limit the generalisation. Third, the patient
population comprised a high proportion of patients with
hepatitis B virus infection. Therefore, this study has lim-
ited applicability to typical North American and European
patients with hepatitis C virus infection or those with alco-
hol dependence. Finally, the sample size was insufficient
for matching SOFA and APACHE III scores among the
patients with and without cirrhosis. Therefore, we cannot
draw definitive conclusions regarding the relatively poor
short-term prognosis of the patients admitted to the ICU
with cirrhosis compared with that of the patients admitted
to the ICU without cirrhosis.Conclusions
Our results provide additional evidence that SOFA scores
differ significantly between patients with and without
cirrhosis matched according to APACHE III scores. The
score-matched analytical data showed that the predictive
accuracy of SOFA is superior to that of APACHE III in
evaluating critically ill patients with cirrhosis. We also
demonstrated that the mean arterial pressure, GCS, and
RIFLE classification play critical roles in determining
prognosis in this subset of patients. When considering
cost-effectiveness and ease of implementation, the SOFA
scale is recommended for evaluating short-term prognosis
in critically ill patients with cirrhosis.
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